Key facts
- This page summarizes William Lewis's Form 4 filing for INSMED Inc (INSM).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Jul 2022, 16:04.
William Lewis - 07 Jul 2022 Form 4 Insider Report for INSMED Inc (INSM)
- Reporting relationship
- Chair and CEO, Director
- Issuer ticker
- INSM
- Reported as of
- 07 Jul 2022
- Net transaction value
- -$660,840
- SEC form
- 4
- Accepted by SEC
- 08 Jul 2022, 16:04:34 UTC
- Prior SEC filing
- 18 May 2022
- Next SEC filing
- 10 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ William H. Lewis, by Michael Smith as Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William Lewis filed Form 4 for INSMED Inc (INSM) on 08 Jul 2022.
Change
- Previous filing in this sequence was filed on 18 May 2022.
- Current net transaction value: -$660,840.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INSM
transaction
Common Stock
Options Exercise
- Transaction value
- $1,561,282
- Shares
- +96,614
- Change %
- +38%
- Price
- $16.16
- Shares after
- 353,330
- Date
- 07 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F2
INSM
transaction
Common Stock
Sale
- Transaction value
- $2,222,122
- Shares
- -96,614
- Change %
- -27%
- Price
- $23.00
- Shares after
- 256,716
- Date
- 07 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INSM
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -96,614
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 07 Jul 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 96,614
- Exercise price
- $16.16
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Footnote F2
Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
Footnote F3
This is the weighted average sales price representing 96,614 shares sold at prices ranging from $23.00 to $23.03 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F4
The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.